5PSQ-043 Nebulised voriconazole in lung transplant recipients: analysis of use, efficacy and tolerability

BACKGROUND: Fungal infection is a significant source of morbidity and mortality in lung-transplant recipients (LTR). To avoid systemic toxicity, various nebulised antifungal agents are used after transplant to prevent or treat invasive fungal infections (IFI). Nebulised liposomal amphotericin B (n-L...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Eur J Hosp Pharm
Glavni autori: Mira, ML Ibarra, Perez, M Aguilar, Carreño, B Basagoiti, Guerrero, A Sanchez
Format: Artigo
Jezik:Inglês
Izdano: BMJ Group 2018
Teme:
Section 5: Patient safety and quality assurance
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535448/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.397
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items